Tatyana Isayeva Selected Research

Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)

6/2007

Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatyana Isayeva Research Topics

Disease

16	Neoplasms (Cancer) 01/2017 - 08/2004
7	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2005
5	Carcinoma (Carcinomatosis) 05/2015 - 06/2007
4	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2008
4	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 06/2007
3	Arteriovenous Fistula 12/2019 - 01/2017
2	Disease Progression 02/2015 - 02/2014
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2015
1	Merkel Cell Carcinoma 01/2014
1	Laryngeal Neoplasms (Laryngeal Cancer) 07/2012
1	Nasopharyngeal Carcinoma 07/2012
1	Squamous Cell Carcinoma of Head and Neck 12/2011
1	Carcinogenesis 05/2009
1	Osteolysis 05/2008
1	Adenocarcinoma 06/2007
1	Ascites 02/2005
1	Hemorrhage 02/2005

Drug/Important Bio-Agent (IBA)

4	EndostatinsIBA 02/2015 - 02/2005
4	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2005
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2019 - 10/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2005
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2017
2	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2015 - 02/2014
2	Oncogene Proteins (Oncogene Protein)IBA 05/2015 - 06/2013
2	Androgen Receptors (Androgen Receptor)IBA 02/2015 - 07/2009
2	Formaldehyde (Formol)FDA Link 01/2014 - 12/2011
2	ParaffinIBA 01/2014 - 12/2011
2	RNA (Ribonucleic Acid)IBA 07/2012 - 12/2011
2	Biological ProductsIBA 12/2011 - 08/2004
2	OsteoprotegerinIBA 12/2009 - 05/2008
2	AngiostatinsIBA 06/2007 - 02/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Conditioned Culture MediaIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 07/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2011
1	Complementary DNA (cDNA)IBA 12/2011
1	AndrogensIBA 07/2009
1	Messenger RNA (mRNA)IBA 05/2009
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 05/2009
1	Estrogens (Estrogen)FDA Link 05/2009
1	CarcinogensIBA 05/2009
1	Fulvestrant (Faslodex)FDA Link 05/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2008
1	Small Interfering RNA (siRNA)IBA 08/2008
1	RANK LigandIBA 05/2008
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 06/2007
1	SynaptophysinIBA 06/2007
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2007
1	Therapeutic UsesIBA 01/2005
1	Pharmaceutical PreparationsIBA 08/2004

Therapy/Procedure

8	Therapeutics 02/2015 - 08/2004
2	Renal Dialysis (Hemodialysis) 12/2019 - 01/2017
1	Castration 02/2015
1	Ligation 12/2011
1	Aftercare (After-Treatment) 06/2007
1	Drug Therapy (Chemotherapy) 01/2005